8 More Big Pharma Events in 2019 You Don't Want to Miss
These are the clinical trial readouts, FDA decisions, and blockbuster-drug launches that will set the tone for the entire industry.
Editors' Picks
Tesla Cuts Prices Again. It's Not Good News.
Frequent price changes might boost sales in the short run, but they will hurt profitability and could damage Tesla's brand in the long run.
NextEra Energy: U.S. Can Hit 50% Renewable Energy by 2030
The world's largest producer of electricity from the wind and sun is surprisingly optimistic about the future of renewable energy.
The 10 Biggest Food Stocks
You might not even think of the top two as food stocks, but they very much are.
Recent articles
Nearly a Third of Workers Are Missing Out on This Easy Way to Save for Retirement
But if you don't have access to this investing option, don't despair.
This Is the Single Best Age to Take Social Security Benefits
A lengthy new study pinpoints the age at which a majority of retirees would get the most out of Social Security.
Chewy's First Public Report Was Pretty Good -- but Still Not Good Enough
Shares of the pet-focused e-commerce company were already more than fairly priced.
No Retirement Savings? 3 Ways to Boost Your Social Security Benefits to Compensate
If you're entering your golden years without a nest egg, you'll need to get more out of Social Security. Here's how.
Solar Energy Provides Another Cautionary Tale
ABB is giving up on solar energy and taking a big hit to do it.
Want to Retire a Millionaire? Follow These 4 Steps
Even if you're not super wealthy, it's still possible to retire with a million-dollar nest egg.
4 Reasons Theme Parks Are Struggling This Summer
It's easy to see what Disney, Universal Studios, and SeaWorld got wrong in Central Florida this season.
Bank of America Keeps This Amazing 4.5-Year Streak Alive
The big bank keeps finding a way to get more profitable.
You May Need More Retirement Income if This Scenario Applies to You
It's a good position to be in, in theory, but a financially precarious one in practice.
Adding Beyond Meat to Its Menu Won't Save Blue Apron
The market reacted irrationally to news that the meal kit maker would offer the popular plant-based burgers.
Will Coca-Cola Earnings Stay Flat in the Second Quarter?
Don't be surprised by a growth slowdown in the beverage giant's upcoming report, scheduled for release Tuesday.
Tesla Cuts Prices Again. It's Not Good News.
Frequent price changes might boost sales in the short run, but they will hurt profitability and could damage Tesla's brand in the long run.
NextEra Energy: U.S. Can Hit 50% Renewable Energy by 2030
The world's largest producer of electricity from the wind and sun is surprisingly optimistic about the future of renewable energy.
The 10 Biggest Food Stocks
You might not even think of the top two as food stocks, but they very much are.
Interactive Brokers Has a Plan to Lure Sports Bettors to Investing
Bet. Learn. Win. Start a brokerage account?
8 More Big Pharma Events in 2019 You Don't Want to Miss
These are the clinical trial readouts, FDA decisions, and blockbuster-drug launches that will set the tone for the entire industry.
The 9 Biggest Tobacco Stocks
There aren't a huge number of U.S.-listed stocks with a tobacco focus, but these companies still combine to be a force in the global industry.
2 Stocks You Can Buy and Hold Forever
These stocks are well-positioned to benefit from this multi-decade trend.
How Bad Will Harley-Davidson's Q2 Report Be?
All signs point towards another depressing quarter of domestic sales declines -- but the motorcycle maker's focus is elsewhere.
Can Facebook Get Past the Antitrust Debacle When It Reports Earnings?
After recent reports of a record-setting fine, it needs to put its history of consumer privacy issues behind it.